Zinc Sulfate in the Treatment of Rosacea: A Randomized, Controlled Trial

• Status: Terminated
• Trial end date: 2008-07-01
• Target enrollment: 0
• Participant gender: All

Summary

Rosacea is a common chronic dermatological condition, characterized by recurrent or persistent redness, permanent dilation of small blood vessel causing small red lesions, and papules/pustules. The signs of rosacea are usually confined to the face, but may appear on the neck, scalp or trunk. Opthalmologic findings are also common. Rosacea is usually described as being most common in fair skinned women over 40. The purpose of the study is to determine whether oral Zinc Sulfate treatment is an effective treatment for facial rosacea.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Essentia Health
• Treatments: Zinc; Zinc Sulfate

Criteria

Inclusion Criteria:

• Diagnosis of facial rosacea made or confirmed by one of the investigators.

• Severity of signs of rosacea "greater than mild" at the time of enrollment.

Exclusion Criteria:

• Treatment for rosacea during the 3 months prior to enrollment.

• Use of zinc dietary supplement > 25 mg per day during the 3 months prior to enrollment ( Most patients taking multivitamins with Zinc, often 15 mg per day, will not be excluded, whereas most patients taking additional Zinc supplements, often 25-50 mg per day or more will be excluded.)

• Diagnosis of rosacea fulminancy.

• Pregnant or breast feeding.